IsoPlexis continues to build its pipeline of revolutionary, single-cell, proteomic biology solutions with novel, tumor cell, proteomic signaling pathway technology BRANFORD, Conn. — IsoPlexis, the leading life sciences company in the single-cell proteomics space, announced today that it has received $2 million in grant funding from the National Cancer Institute’s Small Business Innovation Research (NCI SBIR) Development Center for […]
SAN DIEGO — BIONANO GENOMICS, INC. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr, a platform for ultra-sensitive and ultra-specific structural variation detection in genome analysis, today announced the pricing of an underwritten public offering of 20,937,558 shares of its common stock (or pre-funded warrants to purchase common stock in lieu thereof) […]
Fluorescent Dye Platform Will Enable New Breadth and Depth in Single Cell Analysis DURHAM, N.C. — Phitonex, Inc., developers of next generation fluorescent labels for biomarker detection on single cells, announces that is has closed a $2M seed round led by private investors. In life science research and diagnostics, the number of questions per individual cell is the […]
The study, done in collaboration with the Fred Hutchinson Cancer Research Center, will leverage the Mission Bio Tapestri® Platform to improve the measurement of residual cancerous cells remaining post-treatment SOUTH SAN FRANCISCO, Calif. Mission Bio, Inc., the pioneer in high-throughput single-cell DNA analysis and precision genomics, today announced that it has been awarded a […]
Gardner, MA: New England Peptide, a leading provider of high-quality custom peptides and antibodies to the global life sciences market, today announced the majority recapitalization of the company by Ampersand Capital Partners. Ampersand’s investment will be used to support the company’s worldwide growth initiatives, including fueling the expansion of peptide synthesis capabilities to better serve an […]
San Diego, Calif. — NanoCellect Biomedical Inc., a leader in the development and manufacture of microfluidic cell sorting solutions for cell-based assays, today announced it has received a $1.5 million Phase II Small Business Innovation Research (SBIR) grant through the National Institutes of Health’s National Institute on Drug Abuse to continue its development of imaging […]
PROVIDENCE RI Nabsys, the pioneer in high-definition genome mapping, announced today that it has closed on a $21 million equity round led by Hitachi High-Technologies Corporation. Nabsys will use the funding to finalize product development and support global commercial launch of their HD-Mappingâ„¢ whole-genome electronic mapping platform. HD-Mapping has applications in a wide variety of […]
STONY BROOK, N.Y. – Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNAâ€) (“we,†“us,†“our,†the “Companyâ€), a leader in large-scale PCR-based DNA manufacturing, today announced that the Nasdaq Hearings Panel (the “Panelâ€) , has granted Applied DNA’s request for an extension through December 31, 2019, to comply with all applicable criteria for continued listing of the Company’s […]
SAN DIEGO — Molecular Assemblies, Inc., today announced that it has raised a $12.2 million Series A financing led by iSelect Fund and joined by existing investors, Agilent Technologies, Alexandria Venture Investments, and Keshif Ventures. The proceeds of the financing will be used to advance the company’s proprietary enzymatic DNA synthesis technology to power DNA-based products […]
Wädenswil/Zurich, Switzerland – Creoptix AG, a Switzerland-based company focused on next-generation bioanalytical instruments, today announced that is has raised CHF 8 million in the first closing as part of a Series C financing round. The round was led by Swisscanto Invest by Zürcher Kantonalbank and joined by Waters Corporation (NYSE: WAT) as well as existing private investors. Robert […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
